Xeris doses first patient in phase 2 trial of developmental ready-to-use glucagon in PBH

This article was originally published here

Post-bariatric hypoglycemia (PBH) is a complication of bariatric surgery thought to be related to excessive insulin secretion in response to a meal. PBH can begin to occur one

The post Xeris doses first patient in phase 2 trial of developmental ready-to-use glucagon in PBH appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply